Mercor
Biotech Investment Analyst — Drug Asset & Company Assessment
- Pay
- $120–200/hr
- Type
- Part-time
- Location
- Remote
- Posted
- Aug 5, 2026
Tip: In our experience, people who apply through a referral link have a better chance of being selected, as I’m also working on Mercor.
Free to apply. Our referral link costs you nothing and doesn’t change your pay. If you’re hired, Mercor may pay us a bonus, which keeps this site free. Never pay anyone to get AI training work.
About this role
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales. Responsibilities Create and critique rubrics that analyze commercial drugs and drug-development programs Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions Apply your assessment across the pilot's set of companies (~5–10) Requirements US-based biotech / healthcare investment analyst with a specialist-fund background Familiarity with biotech/pharma development programs Able to assess a drug asset and the…
Categories
Similar jobs
-
Nuclear & Radiological Security Expert New
$50–90/hr
-
Management Consulting Expert
$60–120/hr
-
Financial Due Diligence & Transaction Accounting
$60–120/hr
-
Investment Banking & M&A Expert
$60–120/hr
-
Corporate Finance & Financial Modeling Expert
$60–120/hr
-
Senior Data Scientist and Data Engineering Experts
$120–180/hr